Literature DB >> 26883409

Au nanoparticle decorated graphene nanosheets for electrochemical immunosensing of p53 antibodies for cancer prognosis.

Reda Elshafey1, Mohamed Siaj2, Ana C Tavares3.   

Abstract

The accurate quantification of the level of p53 antibodies in serum is crucial for cancer prognosis. We report a novel and sensitive label-free immunosensor based on gold nanoparticles (Au NPs) self-assembled onto electrochemically reduced graphene oxide (ERGO) for the detection of p53 antibodies. An electrografted p-aminophenol organic layer was used to immobilize graphene oxide (GO) onto the surface of screen printed carbon electrodes (SPCE). The Au NP/ERGO hybrid interface provides a large surface area for the effective immobilization of p53 antigens, as well as it ascertains the bioactivity and stability of immobilized p53 antigens. Scanning electron microscope, Raman and X-ray photoelectron spectroscopies were used to monitor the sensor fabrication and cyclic voltammetry was used to quantify the extent of Au NPs' surface coverage by p53 antigens. Square wave voltammetry (SWV) of a [Fe(CN)6](3-/4-) couple was employed to investigate the immunosensor fabrication and to monitor the binding events between p53 antigens and p53 antibodies. Under optimized experimental conditions, the biosensor displayed good sensitivity and specificity. The p53 antibodies were detected in a concentration as low as 0.088 pg mL(-1) with a linear range from 0.1 pg mL(-1) to 10 ng mL(-1). The high sensitivity of the immunosensor may derive from the high loading of p53 antibodies on Au NPs which increases the number of binding events.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26883409     DOI: 10.1039/c6an00044d

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  8 in total

1.  Cerium oxide-doped PEDOT nanocomposite for label-free electrochemical immunosensing of anti-p53 autoantibodies.

Authors:  Andrés F Cruz-Pacheco; Jennifer Quinchia; Jahir Orozco
Journal:  Mikrochim Acta       Date:  2022-05-25       Impact factor: 5.833

2.  Label-free multiplex electrochemical immunosensor for early diagnosis of lysosomal storage disorders.

Authors:  Haya Abdulkarim; Mohamed Siaj
Journal:  Sci Rep       Date:  2022-06-04       Impact factor: 4.996

3.  Disposable Amperometric Immunosensor for the Determination of Human P53 Protein in Cell Lysates Using Magnetic Micro-Carriers.

Authors:  María Pedrero; F Javier Manuel de Villena; Cristina Muñoz-San Martín; Susana Campuzano; María Garranzo-Asensio; Rodrigo Barderas; José M Pingarrón
Journal:  Biosensors (Basel)       Date:  2016-11-21

Review 4.  Current Technologies of Electrochemical Immunosensors: Perspective on Signal Amplification.

Authors:  Il-Hoon Cho; Jongsung Lee; Jiyeon Kim; Min-Soo Kang; Jean Kyung Paik; Seockmo Ku; Hyun-Mo Cho; Joseph Irudayaraj; Dong-Hyung Kim
Journal:  Sensors (Basel)       Date:  2018-01-12       Impact factor: 3.576

5.  Ultrarapid Measurement of Diagnostic Antibodies by Magnetic Capture of Immune Complexes.

Authors:  Peter D Burbelo; Sreenivasulu Gunti; Jason M Keller; Caryn G Morse; Steven G Deeks; Michail S Lionakis; Amit Kapoor; Qingxue Li; Jeffrey I Cohen; Abner L Notkins; Ilias Alevizos
Journal:  Sci Rep       Date:  2017-06-19       Impact factor: 4.379

6.  Electrochemical Immunosensor for the Early Detection of Rheumatoid Arthritis Biomarker: Anti-Cyclic Citrullinated Peptide Antibody in Human Serum Based on Avidin-Biotin System.

Authors:  Somasekhar R Chinnadayyala; Sungbo Cho
Journal:  Sensors (Basel)       Date:  2020-12-28       Impact factor: 3.576

Review 7.  Current Perspectives in Graphene Oxide-Based Electrochemical Biosensors for Cancer Diagnostics.

Authors:  Dilsat Ozkan-Ariksoysal
Journal:  Biosensors (Basel)       Date:  2022-08-06

Review 8.  Recent advances in graphene-based biosensor technology with applications in life sciences.

Authors:  Janire Peña-Bahamonde; Hang N Nguyen; Sofia K Fanourakis; Debora F Rodrigues
Journal:  J Nanobiotechnology       Date:  2018-09-22       Impact factor: 10.435

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.